Formulation and Regulatory Affairs of Health Products and Pharmaceutical Regulatory Affairs and Patents

A.Y. 2024/2025
8
Max ECTS
64
Overall hours
SSD
CHIM/09
Language
Italian
Learning objectives
The purpose of the course is to introduce the students to knowledge of the relevant European Community legislation concerning Marketing Authorization (MA), as required before the introduction on the market of a medicinal product. In particular biotechnological medicinal products, including biosimilars, are discussed. The legislative aspects of pharmaceutical patent will also be analyzed.
Moreover, the course provides knowledges to understand the right administrative classification and to evaluate the conformity to national and European rules concerning production, placing on the market and distribution of health products, such as cosmetics, food supplements or food for specific groups.
Expected learning outcomes
The student will acquire the knowledge about legislative aspects of medicines for human use and the main health products.
Single course

This course cannot be attended as a single course. Please check our list of single courses to find the ones available for enrolment.

Course syllabus and organization

Single session

Responsible
Lesson period
Second semester
Course syllabus
The syllabus is shared with the following courses:
- [E24-45](https://www.unimi.it/en/ugov/of/af20250000e24-45)
Formulation and Regulatory Affairs of Health Products
CHIM/09 - PHARMACEUTICAL AND TECHNOLOGICAL APPLICATIONS OF CHEMISTRY - University credits: 4
Lessons: 32 hours
Professor: Minghetti Paola
Pharmaceutical Regulatory Affairs and Patents
CHIM/09 - PHARMACEUTICAL AND TECHNOLOGICAL APPLICATIONS OF CHEMISTRY - University credits: 4
Lessons: 32 hours
Professor(s)